NIH has paused patenting of discoveries, slowing their use in developing treatments

What's new in pharma

March 7, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | NIH has paused patenting of discoveries, slowing their use in developing treatments Employees at NIH technology transfer offices have been barred from filing new patent applications, and sharing of research materials halted By Megan Molteni STAT+ | Opinion: Volatile is the new normal for the biotech workforce While working at biotech startups has always involved risk, the biotech industry has recently evolved into an especially volatile dynamic. By Gairik Sachdeva STAT+ | UnitedHealth continues making stealthy deals, pushing deeper into medical care as scrutiny mounts Financial documents show the sprawling conglomerate acquired or created 250 subsidiaries in 2024 as it continues an ambitious vertical integration strategy. By Bob Herman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser